Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cardiovasc Intervent Radiol. 2012 Jun 22;36(2):449–459. doi: 10.1007/s00270-012-0424-y

Table 6.

Efficacy: response by RECIST/EASL criteria per lesion

Response 1 months after initial DEB-TACE (n = 32 lesions)
6 months after initial DEB-TACE (n = 26 lesions)
12 months after initial DEB-TACE (n = 19 lesions)
No. RECIST (%) No. EASL (%) No. RECIST (%) No. EASL (%) No. RECIST (%) No. EASL (%)
Complete response – 2/32 (6) 3/26 (12) 6/26 (23) 4/19 (21) 7/19 (37)
Partial response 5/32 (16) 23/32 (72) 11/26 (42) 10/26 (38) 5/19 (26) 3/19 (16)
Stable disease 26/32 (81) 7/32 (22) 11/26 (42) 10/26 (38) 9/19 (47) 9/19 (47)
Progressive disease 1/32 (3) – 1/26 (4) – 1/19 (5) –